Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
Abstract
Much knowledge has accrued since the 2001 American College of Rheumatology (ACR) guidelines were published to assist clinicians in the prevention and treatment of glucocorticoid-induced osteoporosis (GIO). Therefore, the ACR undertook a comprehensive effort to review the literature and update the GIO guidelines [Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515-1526]. Herein, we review the new guidelines for JBMR readers, highlighting the changes introduced by the 2010 publication. We discuss several patient scenarios for which the new treatment guidelines do not apply, or for which our committee interprets existing literature differently and suggests an alternative approach.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Continued and safety studies for the use of bisphosphonates in children have yet to be established.
“To this end, continued and safety studies for the use of BPs in children have yet to be established [18-20].”
From Prevention of glucocorticoid induced bone changes with beta-ecdysone (2015) · cites this paper as [20]
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · see citing works
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,127 · see citing works
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251 · see citing works
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 1× · see citing works
“GIO is associated with an initial increase in bone resorption((7,8)) and, more importantly, subsequent reduced bone formation((9)) leading to microarchitectural deterioration and a predisposition to fragility fractures.”
BackgroundKhosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650 · see citing works
Use of Inhaled Corticosteroids and Risk of Fractures
van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297 · see citing works
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294 · see citing works
Use of oral corticosteroids and risk of fractures
Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263 · see citing works
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258 · see citing works
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116 · see citing works
Self-citationBisphosphonates: A review of their pharmacokinetic properties
Lin, J. H. (1996) · Bone · doi:10.1016/8756-3282(95)00445-9 · Cited by 933 · see citing works
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914 · see citing works
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848 · see citing works
Grossman, J. M., Gordon, R. D., Ranganath, V. K., Deal, C. L., Caplan, L., Chen, W., Curtis, J. R., Fürst, D. E., McMahon, M. A., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 707 · see citing works
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W., Brown, J. P., Hanley, D. A., Hodsman, A. B., Josse, R. G., Kendler, D. L., Lentle, B. C., Olszynski, W. P., Ste‐Marie, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 683 · see citing works
Reid, D. M., Hughes, R., Laan, R., Sacco-Gibson, N., Wenderoth, D., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 588 · see citing works
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559 · see citing works
Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527 · see citing works
Lane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3914 · Cited by 526 · see citing works
Wallach, S., Cohen, S. B., Reid, D. M., Hughes, R., Hosking, D. J., Laan, R., Doherty, S. M., Maricic, M. J., Rosen, C. J., Brown, J. P., et al. (2000) · Calcified Tissue International · doi:10.1007/s002230001146 · Cited by 512 · see citing works
Saag, K. G., Zanchetta, J. R., Devogelaer, J., Adler, R. A., Eastell, R., See, K., Krege, J. H., Krohn, K., & Warner, M. R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24879 · Cited by 493 · see citing works
Self-citationTestosterone Therapy in Glucocorticoid-Treated Men
Reid, I. R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440100065008 · Cited by 369 · see citing works
Fink, H. A., Milavetz, D. L., Palermo, L., Nevitt, M. C., Cauley, J. A., Genant, H. K., Black, D. M., & Ensrud, K. E. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050314 · Cited by 365 · see citing works
Self-citationThe Reproducibility of a Method to Identify the Overuse and Underuse of Medical Procedures
Shekelle, P., Kahan, J. P., Bernstein, S. J., Leape, L. L., KAMBERG, C. J., & Park, R. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382607 · Cited by 363 · see citing works
INTERMITTENT ETIDRONATE THERAPY TO PREVENT CORTICOSTEROID- INDUCED OSTEOPOROSIS
Dachi, J. O. D. A., Ensen, W. I. G. B., Acques, J., Rown, B., Anley, D. A. H., Osse, R. O. J., Endler, D. A. L. K., Entle, B. R. L., Lszynski, W. O. O., Ouis, L., et al. (1997) · Cited by 360 · see citing works
Cosman, F., Eriksen, E. F., Recknor, C. P., Miller, P. D., Guañabens, N., Kasperk, C. H., Papanastasiou, P., Readie, A., Rao, H., Gasser, J. A., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.238 · Cited by 358 · see citing works
Carbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.97 · Cited by 309 · see citing works
Hemingway, H., Crook, A. M., Feder, G., Banerjee, S., Dawson, J. R., Magee, P., Philpott, S., Sanders, J., Wood, A., & Timmis, A. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440906 · Cited by 262 · see citing works
Crawford, B. A. L., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021827 · Cited by 235 · see citing works
Health-Related Quality of Life and Appropriateness of Knee or Hip Joint Replacement
Quintana, J. M., Escobar, A., Aróstegui, I., Bilbao, A., Azkárate, J., Goenaga, J. I., & Arenaza, J. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.220 · Cited by 232 · see citing works
Shekelle, P. (2004) · Medical Decision Making · doi:10.1177/0272989x04264212 · Cited by 204 · see citing works
Dore, R. K., Cohen, S. B., Lane, N. E., Palmer, W. E., Shergy, W. J., Zhou, L., Wang, H., Tsuji, W. H., & Newmark, R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.112920 · Cited by 194 · see citing works
Altered trabecular architecture induced by Corticosteroids: A Bone Histomorphometric Study
Chappard, D., Legrand, É., Baslé, M. F., Fromont, P., Racineux, J.-L., Rebel, A., & Audran, M. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110516 · Cited by 191 · see citing works
Management of glucocorticoid-induced osteoporosis
Compston, J. E. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.259 · Cited by 191 · see citing works
Corticosteroid-Induced Bone Loss in Men
Pearce, G., Tabensky, D. A., Delmas, P. D., Baker, H. W. G., & Seeman, E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4621 · Cited by 184 · see citing works
Reid, D. M., Adámi, S., Devogelaer, J.-P., & Chines, A. A. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1060-8 · Cited by 160 · see citing works
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
van Staa, T. P., Geusens, P., Pols, H. A. P., Laet, C. E. D. H. D., Leufkens, H. G. M., & Cooper, C. C. (2005) · QJM · doi:10.1093/qjmed/hci029 · Cited by 160 · see citing works
Langdahl, B. L., Marín, F., Shane, E. J., Dobnig, H., Zanchetta, J., Maricic, M. J., Krohn, K., See, K., & Warner, M. R. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0917-y · Cited by 124 · see citing works
Ichikawa, K., Tsutsumi, A., Atsumi, T., Matsuura, E., Kobayashi, S., Hughes, G. R. V., Khamashta, M. A., & Koike, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11 · Cited by 88 · see citing works
The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice
Weinstein, R. S., Jia, D., Powers, C. C., Stewart, S. A., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2004) · Endocrinology · doi:10.1210/en.2003-1133 · Cited by 86 · see citing works
[Fracture risk assessment tool].
Fujiwara, S. (2006) · PubMed · Cited by 83 · see citing works
Clinical utility of dual-energy vertebral assessment (DVA)
Vokes, T., Dixon, L. B., & Favus, M. J. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1461-9 · Cited by 76 · see citing works
Reproduction toxicity studies with pamidronate.
Graepel, P., Bentley, P., Fritz, H., Miyamoto, M., & Slater, S. (1992) · PubMed · Cited by 52 · see citing works
López, I. A. L., Sartori, L., Gianantonio, E. D., Zen, M., Clementi, M., & Doria, A. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.03.002 · Cited by 52 · see citing works
Montecucco, C., Caporali, R. F., Caprotti, P., Caprotti, M., & Notario, A. (1992) · PubMed · Cited by 46 · see citing works
Appropriateness Criteria for Coronary Angiography in Angina: Reliability and Validity
Hemingway, H., Chen, R., Junghans, C., Timmis, A., Eldridge, S. M., Black, N. A., Shekelle, P., & Feder, G. S. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00003 · Cited by 45 · see citing works
Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease
Franchimont, N., & CANALIS, E. M. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00056-9 · Cited by 39 · see citing works
Maternal and fetal outcome after long-term bisphosphonate exposure before conception
Hassen-Zrour, S., Korbaa, W., Bejia, I., Saïdani, Z., & Bergaoui, N. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0983-1 · Cited by 31 · see citing works
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Curtis, J. R., Weinstein, R. S., & Saag, K. G. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50046-x · Cited by 27 · see citing works
Self-citationTechnetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestation.
McKenzie, A. F., Budd, R., Yang, C., Shapiro, B., & Hicks, R. J. (1994) · PubMed · Cited by 18 · see citing works
Danon‐Hersch, N., Samartzis, D., Wietlisbach, V., Porchet, F., & Vader, J.-P. (2010) · Spine · doi:10.1097/brs.0b013e3181b71a79 · Cited by 13 · see citing works
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2 · see citing works
Flagged first, then by citations
1 of the 53 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Glucocorticoid-Induced Osteoporosis and Osteonecrosis
Weinstein, R. S. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.004 · Cited by 367 · see citing works
The diagnosis and management of primary autoimmune haemolytic anaemia
Hill, Q. A., Stamps, R., Massey, E., Grainger, J. D., Provan, D., Hill, A., & the British Society for Haematology (2016) · British Journal of Haematology · doi:10.1111/bjh.14478 · Cited by 277 · see citing works
Management of severe osteoporosis
Miller, P. D. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1124856 · Cited by 185 · see citing works
Glucocorticoids and bone: Local effects and systemic implications
Henneicke, H., Gasparini, S. J., Brennan-Speranza, T. C., Zhou, H., & Seibel, M. J. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.12.006 · Cited by 168 · see citing works
Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview
Wang, L.-T., Chen, L.-R., & Chen, K.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065814 · Cited by 168 · see citing works
Glucocorticoid-induced osteoporosis: An update on effects and management
Buehring, B., Viswanathan, R. K., Binkley, N., & Busse, W. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.08.040 · Cited by 163 · see citing works
Prevention and management of glucocorticoid-induced side effects: A comprehensive review
Caplan, A. S., Fett, N. M., Rosenbach, M. A., Werth, V. P., & Micheletti, R. G. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.062 · Cited by 156 · see citing works
Secondary Causes of Osteoporosis
Hudec, S. M. D., & Camacho, P. M. (2012) · Endocrine Practice · doi:10.4158/ep12059.ra · Cited by 113 · see citing works
Mazziotti, G., Formenti, A. M., Adler, R. A., Bilezikian, J. P., Grossman, A. B., Sbardella, E., Minisola, S., & Giustina, A. (2016) · Endocrine · doi:10.1007/s12020-016-1146-8 · Cited by 112 · see citing works
Self-citationMok, C. C., Ho, L. Y., & Ma, K. M. (2015) · Bone · doi:10.1016/j.bone.2015.03.002 · Cited by 87 · see citing works
Clinical reviews in allergy and immunology
Leung, D. Y. M., Ledford, D. K., Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., et al. (2012) · Cited by 87 · see citing works
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Minisola, S., Cipriani, C., Grotta, G. D., Colangelo, L., Occhiuto, M., Biondi, P., Sonato, C., Vigna, E., Cilli, M., & Pepe, J. (2019) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x19877994 · Cited by 86 · see citing works
Self-citationMechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73 · see citing works
A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures.
Abrahamsen, B., Brask-Lindemann, D., Rubin, K., & Schwarz, P. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2014.69 · Cited by 74 · see citing works
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
On behalf of ABC Group, Scillitani, A., Mazziotti, G., Di Somma, C., Moretti, S., Stigliano, A., Pivonello, R., Giustina, A., & Colao, A. (2014) · Osteoporosis International · doi:10.1007/s00198-013-2588-y · Cited by 62 · see citing works
Majumdar, S. R., Lix, L. M., Yogendran, M. S., Morin, S. N., Metge, C. J., & Leslie, W. D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2645 · Cited by 62 · see citing works
Inhaled Corticosteroids and Bone Health
Chee, C., Sellahewa, L., & Pappachan, J. M. (2015) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401408010085 · Cited by 54 · see citing works
New anabolic therapies for osteoporosis
Minisola, S., Cipriani, C., Occhiuto, M., & Pepe, J. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1719-4 · Cited by 43 · see citing works
Self-citationCai, J., Shao, X., Yang, Q., Yang, Y., Yan, Z., Luo, E., Feng, X., & Jing, D. (2020) · Bone · doi:10.1016/j.bone.2020.115266 · Cited by 41 · see citing works
Systemic lupus erythematosus, bone health, and osteoporosis
Edens, C., & Robinson, A. B. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000197 · Cited by 37 · see citing works
Overman, R. A., Toliver, J. C., Yeh, J., Gourlay, M. L., & Deal, C. L. (2014) · Arthritis Care & Research · doi:10.1002/acr.22346 · Cited by 36 · see citing works
Clinical utility of denosumab for treatment of bone loss in men and women
Adler, R. A., & Gill, R. S. (2011) · Clinical Interventions in Aging · doi:10.2147/cia.s14565 · Cited by 36 · see citing works
Self-citationClinical role of bisphosphonate therapy
Fogelman, I., & Hampson (2012) · International Journal of Women s Health · doi:10.2147/ijwh.s24783 · Cited by 36 · see citing works
Prevention of glucocorticoid induced bone changes with beta-ecdysone
Dai, W., Jiang, L., Lay, Y.-A. E., Chen, H., Jin, G., Zhang, H., Kot, A., Ritchie, R. O., Lane, N. E., & Yao, W. (2015) · Bone · doi:10.1016/j.bone.2015.01.001 · Cited by 30 · see citing works
Majumdar, S. R., Lix, L. M., Morin, S. N., Yogendran, M. S., Metge, C. J., & Leslie, W. D. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130041 · Cited by 27 · see citing works
Aeberli, D., & Schett, G. A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4180 · Cited by 25 · see citing works
Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis
Schurman, L., Bagur, A., Claus-Hermberg, H., Messina, O. D., Negri, A. L., Sánchez, A., González, C. D., Diehl, M., Rey, P., Gamba, J., et al. (2013) · Actualizaciones en osteología · Cited by 22 · see citing works
Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids
Warriner, A. H., & Saag, K. G. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/01.med.0000436249.84273.7b · Cited by 22 · see citing works
Kenanidis, E. I., Potoupnis, M. E., Kakoulidis, P., Leonidou, A. O., Sakellariou, G. T., Sayegh, F. E., & Tsiridis, E. E. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1040387 · Cited by 20 · see citing works
Osteoporosis Update From the 2012 Santa Fe Bone Symposium
Lewiecki, E. M., Adler, R. A., Bilezikian, J. P., Bouxsein, M., Marcus, R., McClung, M. R., Miller, P. D., Tanner, S. B., & Randall, S. (2013) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2013.01.001 · Cited by 17 · see citing works
Self-citationBisphosphonates and glucocorticoid-induced osteoporosis: Efficacy and tolerability
Lespessailles, É. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.08.005 · Cited by 16 · see citing works
Dore, R. K. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s31067 · Cited by 14 · see citing works
Yamamoto, S., Suzuki, A., Sasaki, H., Sekiguchi-Ueda, S., Asano, S., Shibata, M., Hayakawa, N., Hashimoto, S., Hoshinaga, K., & Itoh, M. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0391-z · Cited by 13 · see citing works
Romosozumab: from basic to clinical aspects
Minisola, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.920815 · Cited by 13 · see citing works
Self-citationVilla, P., Moruzzi, M. C., Lassandro, A. P., Leoni, F., Nardo, F. D., de Waure, C., Scambia, G., & for Lazio-GISMO group (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.788631 · Cited by 11 · see citing works
Glucocorticoid-induced osteoporosis: an overview
Kuchuk, N. O., Hoes, J. N., Bijlsma, J. W. J., & Jacobs, J. W. G. (2014) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.14.24 · Cited by 10 · see citing works
Systemic glucocorticoids: important issues and practical guidelines for the dermatologist
Dodiuk‐Gad, R. P., Ish‐Shalom, S., & Shear, N. H. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12642 · Cited by 9 · see citing works
Gu, K.-M., Yoon, S.-W., Jung, S., Baek, M. S., Kim, W., Jung, J., Choi, J.-C., Shin, J., Kim, J. Y., Choi, B.-W., et al. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.152 · Cited by 8 · see citing works
Massafra, U., Migliaccio, S., Bancheri, C., Chiacchiararelli, F., Fantini, F., Leoni, F., Martin, L. S. M., Migliore, A., Muccifora, B., Napolitano, C., et al. (2013) · PubMed · doi:10.3275/8288 · Cited by 8 · see citing works
Xie, J., Tong, A., & Kim, S. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115091 · Cited by 7 · see citing works
Jiang, Y., Fu, Y., Xing, X., Li, M., Wang, O., Xia, W., & Meng, X. (2015) · European journal of medical research · doi:10.1186/s40001-015-0161-1 · Cited by 6 · see citing works
Glucocorticoid-Induced Osteoporosis
Adler, R. A., Weinstein, R. S., & Saag, K. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00049-2 · Cited by 6 · see citing works
Self-citationBrance, M. L., Larroudé, M. S., Somma, L. F., Giacoia, E., Diehl, M., Galich, A. M., Stieben, L. A. R., Maher, M. C., Vega, M. D. L., Ringer, A., et al. (2022) · Reumatología Clínica · doi:10.1016/j.reuma.2022.10.002 · Cited by 4 · see citing works
Meinen, R., Galli-Lysak, I., Villiger, P. M., & Aeberli, D. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1167-8 · Cited by 4 · see citing works
Glucocorticoid-induced osteoporosis
McDermott, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00018-8 · Cited by 2 · see citing works
Brance, M. L., Larroudé, M. S., Somma, L. F., Giacoia, E., Diehl, M., Galich, A. M., Stieben, L. A. R., Maher, M. C., Vega, M. D. L., Ringer, A., et al. (2023) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2022.10.002 · Cited by 2 · see citing works
Skeleton, Inflammatory Diseases of
Aeberli, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00026-x · Cited by 1 · see citing works
Glucocorticoid-Induced Osteoporosis and the New ACR Guideline
Adler, R. A. (2017) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-017-9234-8 · Cited by 1 · see citing works
Self-citationAnabolic Agents for the Treatment of Postmenopausal Osteoporosis
Minisola, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_25 · Cited by 1 · see citing works
Self-citationStrokovna stališča Združenja endokrinologov Slovenije o obravnavi glukokortikoidne osteoporoze
Kocjan, T., Jensterle, M., & Preželj, J. (2018) · Slovenian Medical Journal · doi:10.6016/zdravvestn.2637 · Cited by 1 · see citing works
Basic and clinical aspects of glucocorticoid action in bone
Zhou, H., Cooper, M. S., & Seibel, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00039-7 · Cited by 1 · see citing works
Gimeno, E. J. (2014) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(14)70812-1 · Cited by 1 · see citing works
Les bisphosphonates dans l’ostéoporose cortico-induite : efficacité et tolérance
Lespessailles, É. (2013) · Revue du Rhumatisme · doi:10.1016/j.rhum.2012.09.006
Glucocorticoid-induced osteoporosis; management based on recent major international recommendations
Rathnapala, A., & Somasundaram, N. P. (2014) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v3i2.6366
Glukokortikoidi v nefrologiji I: farmakologija in stranski učinki
Pajek, J., & Jensterle, M. (2015) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1236
Glucokortikoid-induzierte Osteoporose: Pathogenese und Therapie
Aeberli, D., & Oertle, S. (2013) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2013.01648
Osteoporosis inducidapor glucocorticoides
Brance, M. L., & Plantalech, L. (2014) · Revista Argentina de Reumatología · doi:10.47196/rar.v25i3.87
Brance, M. L., & Plantalech, L. (2013) · Actualizaciones en osteología
Parathyroid Hormone and Glucocorticoid-induced Osteoporosis
Adler, R. A., & Giustina, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397166-1.00059-x
Self-citationOstéoporose induite par les glucocorticoïdes: pathogénèse et traitement
Aeberli, D., & Oertle, S. (2013) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2013.01648
Glucocorticoid-induced osteoporosis and Cushing’s syndrome
Saag, K. G., Adler, R. A., & Weinstein, R. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00045-9
Self-citation(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-22102-6.00005-6
Brance, M. L., Larroudé, M. S., Somma, L. F., Stieben, L. A. R., & Brun, L. R. (2023) · Reumatología Clínica · doi:10.1016/j.reuma.2023.09.008
Brance, M. L., Larroudé, M. S., Somma, L. F., Stieben, L. A. R., & Brun, L. R. (2024) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2023.09.005
Hyperparathyroidism: When to Proceed with Surgery
Cetani, F., Saponaro, F., Apicella, M., Mazoni, L., & Marcocci, C. (2023) · Endocrinology · doi:10.1007/978-3-030-19632-5_2-1
- Authors
- Hansen, K. E., Wilson, H. A., Zapalowski, C., Fink, H. A., Minisola, S., & Adler, R. A.
- Affiliations
- University of Wisconsin–Madison (US)
- The Bone Health Center, Newport News, VA, USA
- Denver Center for Bone Health, Denver, CO, USA
- Minneapolis VA Medical Center (US)
- Sapienza University of Rome (IT)
- Virginia Commonwealth University (US)
- Corresponding author
- Hansen, Karen E
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-30
- Volume
- 26
- Issue
- 9
- Pages
- 1989-1996
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1970580865
- Cited by
- 65
- References
- 53
- Citations by year
- 2024: 1 · 2023: 4 · 2022: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 10 · 2014: 10 · 2013: 16 · 2012: 7
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- American Society for Bone and Mineral Research
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- glucocorticoid-induced osteoporosis, osteoporosis prevention, osteoporosis treatment, guideline revision, glucocorticoid therapy, treatment guidelines
- MeSH terms
- Diphosphonates, Glucocorticoids, Humans, Osteoporosis, Hormone Replacement Therapy, Uncertainty, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
